Note: THAA-NC members pay the Member & co-sponsor rate. Please indicate it at registration.
Synthetic Biology & Cleantech: Can 'Artificial Life' Save 'Real Life'?
Harvard Club of San Francisco
Cleantech Thought Leader Series
On Thursday October 7, 2010, the Harvard Club of San Francisco invites members and guests to the sixth installment of the Cleantech Thought Leader Series. We'll meet again at the University Club in San Francisco for an evening session on synthetic biology and clean energy, with the country's top synthetic biology entrepreneurs.
Microbiologist and bioinformatics expert Doug Hershberger, Ph.D. leads a panel of top entrepreneurs using synthetic biology to create alternatives to petro fuels and chemicals.
· Robert Blazej, Ph.D. Allopartis, Co-Founder & President. Allopartis Biotechnologies is a San Francisco-based startup developing tailored enzymes for the efficient conversion of cellulosic biomass into fermentable sugars for renewable chemical and fuel production. Robert is co-inventor of Allopartis' core technology, the AlloScreen and currently leads research to apply the technology to cellulolytic enzymes.
· Jack D. Newman, Ph.D Amyris, Co-Founder and Sr. VP Research. Amyris applies an industrial synthetic biology platform to provide high-performing alternatives to petroleum-sourced fuels and chemicals. Jack is an inventor of the original patented technology underpinning the Amyris production platform, work that led to a $42M grant funded by the Bill and Melinda Gates Foundation, and leads a team of over 80 scientists and engineers in the mission to produce renewable fuels and chemicals that are cost competitive with petroleum
· Stephen del Cardayre, Ph.D. LS9, VP Research & Development. LS9 engineers a wide range of DesignerMicrobes used in a proprietary 1-step fermentation process to produce renewable fuels and sustainable chemicals. Stephen has broad responsibility for research and development, external collaborations, and day-to-day operations at LS9.
· Damien Perriman Verdezyne, VP Business Development. Founded as a synthetic gene provider to the pharmaceutical and industrial enzyme businesses, Verdezyne focuses on fermentation pathway engineering for renewable fuels and chemicals. Damien develops partnerships to commercialize Verdezyne's proprietary bioprocesses for converting renewable raw materials to biobased industrial products.
Meet with synthetic biology's top entrepreneurs at the Harvard Club of San Francisco.
Thur Oct. 7, 2010 | 6:00-8:30 pm
6:00-7:00 Dinner and Networking
7:00-8:30 Presentations and Q&A
Members & Co-Sponsoring Orgs: $25
Cost includes dinner.
The University Club
800 Powell Street
San Francisco, CA 94108
About the series . . .
The Cleantech Thought Leader Series introduces the Harvard Club community and guests to thought leaders working on the many front lines of clean energy technology. The series is chaired by Augie Rakow, a technology and venture finance attorney and Board Member of the Harvard Club of San Francisco. Send comments and suggestions to augierakow@...
Sponsor Orrick Herrington & Sutcliffe LLP is a global law firm with 22 offices worldwide and specialized expertise in energy technology law.
Energy Startup Atty, Orrick
Cleantech Series Chair, Harvard Club of SF